Leo Pharma

Leo

Biotech

Leo's $435M deal for Tanabe skin disease drug awaiting FDA nod

Leo is sticking to its mission of strengthening its pipeline in 2026, securing a rare skin disease drug awaiting an approval decision by the FDA.

Marissa Russo Aug 18, 2026 3:00am

skin cells epidermis layers lotion serum

Leo pays $50M for Replay and its skin disease gene therapy

Apr 30, 2026 9:00am

Leo

Fierce Pharma

JPM26: Leo Pharma sharpens its eye for dermatology dealmaking

Jan 13, 2026 2:45pm

parasailing over clouds in Salzburg Austria

Recursion refreshes leadership with CEO swap—Chutes & Ladders

Nov 7, 2025 8:30am

Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

BMS oncology head swings to Syndax—Chutes & Ladders

May 16, 2025 8:30am

An arrow incrementally going up stairs before pointing straight up Blue background

Leo's eczema prospect hits primary endpoint in phase 2b

May 9, 2025 7:30am